The primary objective is to quantify the learning process of self infusion and the self infusion procedure.
ID
Bron
Verkorte titel
Aandoening
haemophilia, Home treatment, prophylaxis, intravenous infusion, learningprocess.
Ondersteuning
Heidelberglaan 100, PO box 85500
3508 GA Utrecht, the Netherlands
Baxter Healthcare Corporation; unrestricted grant.
One Baxter Parkway
Deerfield, IL 60015-4625, United States
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Quantification of the learning process of self infusion and the self infusion procedure, that will serve as a base-line for futher research to improve adherence.
Achtergrond van het onderzoek
The primary objective of this retro/prospective observational study, is to quantify the process of Home treatment for haemophilia patients. The datacollection is combined with the regular nursing consultation.
Doel van het onderzoek
The primary objective is to quantify the learning process of self infusion and the self infusion procedure.
Onderzoeksopzet
Data collection:
1. For research on self infusion: 3 years;
2. Retrospective data: 0.3 years.
Data Analysis: 0.5 years;
Report: 0.5 years.
Onderzoeksproduct en/of interventie
This study comprises a retro- and prospective observational study which is combined with a nursing consultation. The present project will expand the regular nursing consultation with a history, timing of infusion and an introduction of home-visits to patients who are using home-treatment since more than 1 year.
Publiek
L.H. Schrijvers
University Medical Center Utrecht
Van Creveldkliniek/ Department of Hematology
Utrecht 3508 GA
The Netherlands
+31 (0)88 7551709
L.H.schrijvers-3@umcutrecht.nl
Wetenschappelijk
L.H. Schrijvers
University Medical Center Utrecht
Van Creveldkliniek/ Department of Hematology
Utrecht 3508 GA
The Netherlands
+31 (0)88 7551709
L.H.schrijvers-3@umcutrecht.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. All haemophilia or Von Willebrand type III patients or caretakers of children (with or without CVAD) treated with prophylaxis (possible learning for self infusion);
2. Patients who are treated at the van Creveldkliniek Utrecht, Haemophilia Treatment Centre Amsterdam, or Erasmus Medical Centre Rotterdam, in the estimated period from of 3 years.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
Patients who are treated on demand.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL2295 |
| NTR-old | NTR2686 |
| Ander register | METC UMCU : 10-269/ C |
| ISRCTN | ISRCTN wordt niet meer aangevraagd. |